Supplementary insurance coverage for complementary health services (Yes) 202 55.0 Has a family physician (Yes) 308 83.5 Comorbid anxiety disorder ... any psychotropic medication 239 64.1 SSRIs ...
Other medication options for late-life GAD ... and serotonin norepinephrine reuptake inhibitors are indicated for generalized anxiety disorder. Cognitive behavioural therapy is a gold standard ...
ITI-1284 is under clinical development by Intra-Cellular Therapies and currently in Phase II for Generalized Anxiety Disorder (GAD).
Scientists have identified the brain circuits behind panic attacks, offering insights into new treatments for panic disorder.
Cellular’s neuropsychiatric assets is Caplyta, a pill approved for schizophrenia and bipolar depression and proposed for ...
Psychedelic drug company Mind Medicine Inc. (MindMed) (NASDAQ: MNMD) published its 2025 Investor Presentation this week with ...
Johnson & Johnson announced Monday its agreement to acquire biopharmaceutical company Intra-Cellular Therapies Inc. for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback